Clinical Trial: FINEPKT - Finerenone in Proteinuria Patients After Kidney Transplan

U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07356388) titled 'FINEPKT - Finerenone in Proteinuria Patients After Kidney Transplan' on Dec. 17, 2025.

Brief Summary: The goal of this clinical trial is to learn if Finerenone works to treat proteinuria patients after kidney transplantation. It will also learn about the safety of Finerenone. The main questions it aims to answer are:

Does Finerenone lower the number of UACR values in kidney transplant recipients?? What medical problems do participants have when taking Finerenone? Researchers will compare Finerenone to Dapagliflozin to see if Finerenone works to treat proteinuria patients after kidney transplantation.

Study Start Date: Jan. 30, 202...